Infections Hepatitis C

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Hepatitis C Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Hepatitis C Projects
--BioPartners GmbH
--Biolex Therapeutics
--DAIICHI SANKYO COMPANY, LIMITED
--CSL Limited
--Human Genome Sciences Inc
--Gilead Sciences Inc
--Intercell AG
--Intarcia Therapeutics, Inc.
--Medivir AB
--Kemin Industries, Inc.
--Mochida Pharmaceutical Co., Ltd.
--Meiji Seika Kaisha, Ltd.
--Pfizer Inc
--Novartis AG
--Schering-Plough Corp
--Roche Holdings Ltd
--Tibotec BVBA
--SciClone Pharmaceuticals Inc
--Wyeth
--Vertex Pharmaceuticals Inc

--Top Companies in early stage Hepatitis C Projects
--Achillion Pharmaceuticals Inc
--Abbott Laboratories
--BioCryst Pharmaceuticals Inc
--AstraZeneca Plc
--Genelabs Technologies Inc
--Biolex Therapeutics
--HanAll Pharmaceutical
--Gilead Sciences Inc
--Innogenetics
--Idenix Pharmaceuticals Inc
--Merck & Co Inc
--Intarcia Therapeutics, Inc.
--Novartis AG
--Nautilus Biotech
--Phenomix Corporation
--Pharmasset, Inc.
--REPLICor Inc.
--Protiva Biotherapeutics Inc
--Vertex Pharmaceuticals Inc
--Roche Holdings Ltd

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View